Login / Signup

Review of valiltramiprosate (ALZ-801) for the treatment of Alzheimer's disease: a novel small molecule with disease modifying potential.

Daniel LeeInga M AntonsdottirEmily D ClarkAnton P Porsteinsson
Published in: Expert opinion on pharmacotherapy (2024)
Valiltramiprosate's clinical trial data show early indications of efficacy with potential disease modifying effect in AD.
Keyphrases
  • small molecule
  • clinical trial
  • electronic health record
  • study protocol
  • big data
  • combination therapy
  • machine learning
  • phase ii
  • artificial intelligence
  • data analysis
  • climate change